The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
In Vitro Evidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSV tk Retroviral Gene Therapy
Abstract
Tumor cells transduced with a retroviral vector expressing a herpes virus thymidine kinase (HSV tk) gene are rendered sensitive to the antiherpetic drug, ganciclovir. The bystander effect refers to the observation that not all cells need be transduced to eradicate the cell population by treatment with ganciclovir. We demonstrate that metabolic cooperation can account for this bystander effect. When HT1080 human fibrosarcoma cells marked with a lacZ gene (LZ+5) were cocultured with HT1080 cells transduced with a retrovirus expressing HSVtk (HT1080tk11), at a density at which the majority of cells were in contact, both HT1080tk11 and LZ+5 cells were killed by ganciclovir. When cells were cocultured at a low density where the majority of cells are not in contact with one another, however, only the HT1080tk11 cells were killed. This result suggests that cell contact with HT1080tk11 cells is necessary to render the HSVtk– LZ+5 cells sensitive to ganciclovir. Because involvement of metabolic cooperation in the killing of the LZ+5 cells would require not only contact between HT1080tk11 and LZ+5 cells but also the capacity to transfer small cytotoxic molecules from the former cell to the latter, transfer of radioactive molecules between the two cell lines was assessed by autoradiography after treatment of a coculture with [3H]ganciclovir. Isolated HT1080tk11 cells incorporated the labeled ganciclovir into their nuclei, whereas isolated LZ+5 cells did not. LZ+5 cells incorporated [3H]ganciclovir, only when in contact with HT1080tk11 cells. These findings indicate that a ganciclovir metabolic product, presumably a phosphorylated form, can pass from HSV tk+ to HSV tk– cells and mediate cytotoxicity as a consequence of direct contact. The use of retroviral vectors expressing the herpes simplex virus thymidine kinase (HSV tk) gene has an intrinsic significant advantage as a strategy for gene therapy of tumours. Not all cells of a tumor need to be infected to render the tumor sensitive of the antiherpetic drug, ganciclovir. The conferral of ganciclovir sensitivity to uninfected cells has been designated as the “bystander effect.” This paper explores the possibility that metabolic cooperation plays a major role in the manifestation of this phenomenon. Metabolic cooperation involves the transfer of low-molecular-weight molecules (< 1,000) between adjacent cells via gap junctions. During ganciclovir treatment, phosphorylated ganciclovir derived from HSV tk+ cells can be transferred to adjacent HSV tk– cells and cause the death of these uninfected cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., & Blaese, R. M. (1992) · Science · doi:10.1126/science.1317968 · Cited by 1,509
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895 · Cited by 1,370
Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230904 · Cited by 1,318
Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., & Frost, P. (1990) · Cell · doi:10.1016/0092-8674(90)90591-2 · Cited by 916
Metabolic Coupling, Ionic Coupling and Cell Contacts
GILULA, N. B., REEVES, O. R., & STEINBACH, A. (1972) · Nature · doi:10.1038/235262a0 · Cited by 677
Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transfered by Retroviral Vectors
Moolten, F. L., & Wells, J. M. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.4.297 · Cited by 507
In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M., & Oldfield, E. H. (1993) · PubMed · Cited by 433
Gänsbacher, B., Bannerji, R., Daniels, B. F., Zier, K. S., Cronin, K. A., & Gilboa, E. (1990) · PubMed · Cited by 414
9-(1,3-Dihydroxy-2-propoxymethyl)guanine: a new potent and selective antiherpes agent
Martin, J. C., Dvorak, C. A., Smee, D. F., Matthews, T. R., & Verheyden, J. P. H. (1983) · Journal of Medicinal Chemistry · doi:10.1021/jm00359a023 · Cited by 341
Cited by
Rainov, N. G. (2000) · Human Gene Therapy · doi:10.1089/104303400750038499 · Cited by 698
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L. M., et al. (1997) · Nature Medicine · doi:10.1038/nm1297-1354 · Cited by 668
Gene Therapy for Cancer: What Have We Done and Where Are We Going?
Roth, J. A., & Cristiano, R. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.21 · Cited by 635
Cell-cell communication in carcinogenesis
Trosko, J. E. (1998) · Frontiers in Bioscience · doi:10.2741/a275 · Cited by 515
COMMENTARY: Role of connexin genes in growth control
Yamasaki, H., & Naus, C. C. G. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1199 · Cited by 456
Mesnil, M., Piccoli, C., Tiraby, G., Willecke, K., & Yamasaki, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1831 · Cited by 411
Gap junctions and cancer: communicating for 50 years
Aasen, T., Mesnil, M., Naus, C. C., Lampe, P. D., & Laird, D. W. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.105 · Cited by 369
Prodrugs for improving tumor targetability and efficiency
Mahato, R., Tai, W., & Cheng, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.002 · Cited by 353
Connexins: Key Mediators of Endocrine Function
Bosco, D., Haefliger, J.-A., & Meda, P. (2011) · Physiological Reviews · doi:10.1152/physrev.00027.2010 · Cited by 169
Metadata
- Authors
- Li Bi, W., Parysek, L. M., Warnick, R., & Stambrook, P. J.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1993-12
- Volume
- 4
- Issue
- 6
- Pages
- 725-731
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1973504318
- Cited by
- 416
- References
- 20
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.